TELA Bio (TELA) Net Margin (2018 - 2026)

TELA Bio's (TELA) quarterly Net Margin came in at 64.39% in Q1 2026, down 357.0% year-on-year from 25.06% in Q1 2025, and down 51.05% quarter-over-quarter from 42.63% in Q4 2025.

TELA Bio (TELA) Net Margin (2018 - 2026) Analysis & Trends

TELA Bio's Net Margin history runs 9 years deep, the most recent figure standing at 64.39% for Q1 2026.

  • On a quarterly basis, Net Margin fell 357.0% year-over-year to 64.39% in Q1 2026; TTM through Mar 2026 was 49.12%, a 4212.0% decrease from a year earlier, with the FY2025 full-year figure at 48.19%, down 6059.0% from the prior year.
  • Net Margin slipped to 64.39% in Q1 2026 per TELA's latest filing, from 42.63% in the prior quarter.
  • Across five years, Net Margin topped out at 165.72% in Q4 2024 and bottomed at 135.77% in Q1 2022.
  • The 5-year median for Net Margin is 76.49% (2023), against an average of 60.31%.
  • Across the five-year window, Net Margin jumped 24221 bps in 2024 and sank 20835 bps in 2025, its largest moves.
  • Year by year, Net Margin stood at 83.2% in 2022, then advanced by 8 bps to 76.49% in 2023, then surged by 317 bps to 165.72% in 2024, then sank by 126 bps to 42.63% in 2025, then slumped by 51 bps to 64.39% in 2026.
  • Per Business Quant, the three latest TELA Net Margin figures stand at 64.39% (Q1 2026), 42.63% (Q4 2025), and 41.58% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.65%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.38%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 12.84%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 16.74%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.01%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 TELA Bio 40.65 Mn 1.11 Mn 12.52 Mn -64.39%

Historic Data

Download Data
DateValue
Mar 31, 2026 -64.39%
Dec 31, 2025 -42.63%
Sep 30, 2025 -41.58%
Jun 30, 2025 -49.13%
Mar 31, 2025 -60.82%
Dec 31, 2024 165.72%
Sep 30, 2024 -54.71%
Jun 30, 2024 -78.30%
Mar 31, 2024 -34.10%
Dec 31, 2023 -76.49%
Sep 30, 2023 -76.50%
Jun 30, 2023 -85.29%
Mar 31, 2023 -104.96%
Dec 31, 2022 -83.20%
Sep 30, 2022 -95.77%
Jun 30, 2022 -107.35%
Mar 31, 2022 -135.77%
Dec 31, 2021 -102.15%
Sep 30, 2021 -147.86%
Jun 30, 2021 -194.64%